Page 1 of Clinical Trials for Exemestane, 122 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Safety and Efficacy of AZD4547 in Combination With Exemestane Versus Exemestane Alone in ER+ Breast Cancer Patients
Last Updated: February 28, 2012
Condition(s): Breast Cancer
2
Terminated
Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
Last Updated: March 28, 2012
Condition(s): Advanced Breast Cancer
3
Completed
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane
Last Updated: March 27, 2012
Condition(s): Breast Neoplasms
4
Terminated
Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
Last Updated: September 29, 2011
Condition(s): Early Breast Cancer
5
Terminated
Adjuvant Post-Tamoxifen Exemestane Trial
Last Updated: December 16, 2008
Condition(s): Breast Cancer
6
Completed
Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant
Last Updated: June 11, 2009
Condition(s): Breast Neoplasms
7
Recruiting
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Last Updated: May 14, 2012
Condition(s): Her2 Negative Breast Cancer Patients
8
Active, not recruiting
Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
Last Updated: April 18, 2012
Condition(s): Breast Cancer; Estrogen Receptor-Positive Breast Cancer; Breast Cancer, Estrogen Receptor-Positive; ER+ Breast Cancer
9
Completed
Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding
Last Updated: December 22, 2011
Condition(s): Breast Cancer
10
Not yet recruiting
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Last Updated: May 22, 2012
Condition(s): Breast Neoplasms
11
Completed
Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
Last Updated: June 29, 2011
Condition(s): Metastatic Breast Cancer
12
Completed
Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
Last Updated: February 11, 2010
Condition(s): Breast Neoplasms
13
Terminated
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Last Updated: May 9, 2012
Condition(s): Breast Neoplasms
14
Terminated
Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women
Last Updated: February 14, 2012
Condition(s): Breast Neoplasms
15
Active, not recruiting
Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Last Updated: November 3, 2011
Condition(s): Breast Cancer
16
Completed
Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer
Last Updated: December 22, 2011
Condition(s): Breast Neoplasms
17
Active, not recruiting
Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer
Last Updated: February 15, 2012
Condition(s): Breast Cancer
18
Active, not recruiting
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Last Updated: May 4, 2012
Condition(s): Breast Cancer
19
Terminated
Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer
Last Updated: January 24, 2012
Condition(s): Metastatic Breast Cancer
20
Terminated
A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
Last Updated: March 8, 2012
Condition(s): Breast Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Exemestane

Page 1 of Clinical Trials for Exemestane, 122 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About